Genomma Lab Company Top Insiders
GNMLF Stock | USD 1.27 0.00 0.00% |
Genomma Lab employs about 2.3 K people. The company is managed by 9 executives with a total tenure of roughly 5360 years, averaging almost 595.0 years of service per executive, having 255.22 employees per reported executive. Examination of Genomma Lab's management performance can provide insight into the company performance.
Efran Crdova Insider Deputy Sec |
Engineer Galland Insider Exec CFO |
Genomma |
Genomma Lab Management Team Effectiveness
The company has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1264 %, meaning that it generated $0.1264 on every $100 dollars invested by stockholders. Genomma Lab's management efficiency ratios could be used to measure how well Genomma Lab manages its routine affairs as well as how well it operates its assets and liabilities.Genomma Lab Workforce Comparison
Genomma Lab Internacional is one of the top stocks in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 22,019. Genomma Lab retains roughly 2,297 in number of employees claiming about 10% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2. Genomma Lab Internacional Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Genomma Lab Internacional Price Series Summation is a cross summation of Genomma Lab price series and its benchmark/peer.
Genomma Lab Notable Stakeholders
A Genomma Lab stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Genomma Lab often face trade-offs trying to please all of them. Genomma Lab's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Genomma Lab's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Efran Crdova | Deputy Sec | Profile | |
Engineer Galland | Exec CFO | Profile | |
Marianne Velasco | Global HR | Profile | |
Mximo Juda | Advisor | Profile | |
L Porres | Legal Officer | Profile | |
Daniel Neria | Head Relations | Profile | |
Jorge Valderrama | Chief Officer | Profile | |
Juan Sparvieri | Ex COO | Profile | |
Alejandro Patio | Media, Relations | Profile |
About Genomma Lab Management Performance
The success or failure of an entity such as Genomma Lab Internacional often depends on how effective the management is. Genomma Lab management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genomma management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genomma management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico. Genomma Lab operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2327 people.
Genomma Lab Workforce Analysis
Traditionally, organizations such as Genomma Lab use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Genomma Lab within its industry.Genomma Lab Manpower Efficiency
Return on Genomma Lab Manpower
Revenue Per Employee | 6.7M | |
Revenue Per Executive | 1.7B | |
Net Income Per Employee | 569.4K | |
Net Income Per Executive | 145.3M |
Complementary Tools for Genomma Pink Sheet analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
CEOs Directory Screen CEOs from public companies around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |